A compound according to Formula I: wherein: Rz and Rz' are independently selected from H, (C 1-4)alkyl, O(C 1-4)alkyl, (C=O)O(C 1-4)alkyl, halogen, OH, oxo, cycloalkyl, -((C 1-4)alkylene)-cycloalkyl, heterocyclyl, phenyl, NH 2, N(R b) 2, S 2 -Z, CF 3, CHF 2 and CN, said N(R b) 2, alkyl, cycloalkyl and heterocyclyl are optionally substituted with OH, oxo, CN, halogen, NH 2, (C 1-4)alkyl, O(C 1-4)alkyl, heterocyclyl and N(R b) 2, and said alkyl and phenyl are optionally substituted with halogen, O(C 1-4)alkyl and N(R b) 2; or Rz and Rz' can come together with the nitrogen to which they are attached and form a cyclic, bicyclic or spirocyclic moiety containing 3-9 atoms selected from C, O, N and S, said cyclic, bicylic or spirocyclic moiety optionally substituted with one to three substituents independently selected from H, (C 1-4)alkyl, O(C 1-4)alkyl, (C=O)O(C 1-4)alkyl, halogen, OH, oxo, cycloalkyl, heterocyclyl, NH 2, N(R b) 2, S 2 -Z, CF 3, CHF 2 and CN, wherein said N(R b) 2, alkyl, cycloalkyl and heterocyclyl are optionally substituted with OH, oxo, halogen, NH 2, (C 1-4)alkyl, O(C 1-4)alkyl and N(R b) 2, and said alkyl is optionally substituted with halogen, O(C 1-4)alkyl and N(R b) 2; Z is (C 1-4)alkyl; X is N or C, wherein when X is N then the dashed line is absent and when X is C the dashed line represents a double bond; Y is N or CH; R 1a is H or (C 1-4)alkyl; R 1b is H, OH or (C 1-4)alkyl; R2a is Cl or (C 1-4)alkyl; R 2b is cyclopropyl, cyclobutyl, oxetanyl or azetidinyl, each optionally substituted with (C 1-4)alkyl, F, CF 3, CHF 2 or CN; R 2c is H or F; R b is selected from H and (C 1-4)alkyl; and R 3 is H or (C 1-4)alkyl; or a pharmaceutically acceptable salt thereof. Rz and Rz' are independently selected from H, (C 1-4)alkyl, O(C 1-4)alkyl, (C=O)O(C 1-4)alkyl, halogen, OH, oxo, cycloalkyl, -((C 1-4)alkylene)-cycloalkyl, heterocyclyl, phenyl, NH 2, N(R b) 2, S 2 -Z, CF 3, CHF 2 and CN, said N(R b) 2, alkyl, cycloalkyl and heterocyclyl are optionally substituted with OH, oxo, CN, halogen, NH 2, (C 1-4)alkyl, O(C 1-4)alkyl, heterocyclyl and N(R b) 2, and said alkyl and phenyl are optionally substituted with halogen, O(C 1-4)alkyl and N(R b) 2; or Rz and Rz' can come together with the nitrogen to which they are attached and form a cyclic, bicyclic or spirocyclic moiety containing 3-9 atoms selected from C, O, N and S, said cyclic, bicylic or spirocyclic moiety optionally substituted with one to three substituents independently selected from H, (C 1-4)alkyl, O(C 1-4)alkyl, (C=O)O(C 1-4)alkyl, halogen, OH, oxo, cycloalkyl, heterocyclyl, NH 2, N(R b) 2, S 2 -Z, CF 3, CHF 2 and CN, wherein said N(R b) 2, alkyl, cycloalkyl and heterocyclyl are optionally substituted with OH, oxo, halogen, NH 2, (C 1-4)alkyl, O(C 1-4)alkyl and N(R b) 2, and said alkyl is optionally substituted with halogen, O(C 1-4)alkyl and N(R b) 2; Z is (C 1-4)alkyl; X is N or C, wherein when X is N then the dashed line is absent and when X is C the dashed line represents a double bond; Y is N or CH; R 1a is H or (C 1-4)alkyl; R 1b is H, OH or (C 1-4)alkyl; R2a is Cl or (C 1-4)alkyl; R 2b is cyclopropyl, cyclobutyl, oxetanyl or azetidinyl, each optionally substituted with (C 1-4)alkyl, F, CF 3, CHF 2 or CN; R 2c is H or F; R b is selected from H and (C 1-4)alkyl; and R 3 is H or (C 1-4)alkyl;